Using genetic findings in autism for the development of new pharmaceutical compounds. (Q38167615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Using genetic findings in autism for the development of new pharmaceutical compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Stefan Aigner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

David Collier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jeffrey C Glennon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

6

Ravi Jagasia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Jacob A S Vorstman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Will Spooren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jan K Buitelaar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

30 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1063-1078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

Genomic-scale prioritization of drug targets: the TDR Targets database

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Imaging-genetics in autism spectrum disorder: advances, translational impact, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism as a strongly genetic disorder: evidence from a British twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

The mGluR theory of fragile X mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism genetics: searching for specificity and convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

21 January 2018

The postsynaptic density

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A synaptic trek to autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Why Have Drug Treatments Been So Disappointing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Drug design by machine learning: support vector machines for pharmaceutical data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association between a GABRB3 polymorphism and autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Experimental models of Rett syndrome based on Mecp2 dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism spectrum disorders: from immunity to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

An association analysis of microsatellite markers across the Prader-Willi/Angelman critical region on chromosome 15 (q11-13) and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Peripheral and central inflammation in autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genetic architecture in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Do common variants play a role in risk for autism? Evidence and theoretical musings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Correction of fragile X syndrome in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Medications for adolescents and young adults with autism spectrum disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Translational approaches to the biology of Autism: false dawn or a new era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Reversing neurodevelopmental disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

PTEN: one gene, many syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

In silico approaches to mechanistic and predictive toxicology: an introduction to bioinformatics for toxicologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

The genetics of autistic disorders and its clinical relevance: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Novel evidence-based systemic lupus erythematosus responder index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Immune transcriptome alterations in the temporal cortex of subjects with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Novel de novo SHANK3 mutation in autistic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Immunological and autoimmune considerations of Autism Spectrum Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

PTEN mutation in a family with Cowden syndrome and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism and oxytocin: new developments in translational approaches to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genomic and epigenetic evidence for oxytocin receptor deficiency in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Reversal of neurological defects in a mouse model of Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Altered synaptic plasticity in a mouse model of fragile X mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism spectrum disorders and underlying brain pathology in CHARGE association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Disruption of neurexin 1 associated with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Synaptic plasticity, a symphony in GEF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Common genetic variants, acting additively, are a major source of risk for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A randomised controlled trial of bumetanide in the treatment of autism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genes associated with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Navigating chemical space for biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Molecular mechanisms of mTOR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Finding the missing heritability of complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Structural variation of chromosomes in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Actin-based plasticity in dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

High actin concentrations in brain dendritic spines and postsynaptic densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Contribution of SHANK3 mutations to autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

EU-AIMS: a boost to autism research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

The impact of MeCP2 loss- or gain-of-function on synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Synaptic scaffold evolution generated components of vertebrate cognitive complexity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Global mapping of pharmacological space

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Functional impact of global rare copy number variation in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

AKAPs integrate genetic findings for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

De novo mutations revealed by whole-exome sequencing are strongly associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

The long-range interaction landscape of gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Using bioinformatics in gene and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Dysregulation of mTOR signaling in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

AMPAKINE enhancement of social interaction in the BTBR mouse model of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

MicroRNAs in disease and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A humanoid mouse model of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

In silico research in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Scaffold proteins at the postsynaptic density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Gene regulatory network reconstruction using Bayesian networks, the Dantzig Selector, the Lasso and their meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Genetic causes of developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

A double hit implicates DIAPH3 as an autism risk gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

No evidence that common genetic risk variation is shared between schizophrenia and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Systems-based discovery advances drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Active learning with support vector machines in the drug discovery process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Autism overflows: increasing prevalence and proliferating theories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Oxytocin, sexually dimorphic features of the social brain, and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Microsatellite marker in gamma - aminobutyric acid - a receptor beta 3 subunit gene and autism spectrum disorders in Korean trios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

21 January 2018

A motor driving PTEN.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

PTEN signaling in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3334-Z

Why have drug treatments been so disappointing?

21 January 2018

1 reference

12 December 2020

Autistic disturbances of affective contact

1 reference

12 December 2020

Behavioral and cognitive aspects of tuberous sclerosis complex

1 reference

12 December 2020

The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)

1 reference

12 December 2020

Genetics of autism spectrum disorders

1 reference

12 December 2020

Galaxy: a web-based genome analysis tool for experimentalists

1 reference

12 December 2020

The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals

1 reference

12 December 2020

Autistic-like behavior in CHARGE syndrome

1 reference

12 December 2020

10.1007/S00213-013-3334-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 March 2020

1028049544

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292384%20AND%20SRC:MED&resulttype=core&format=json